FdaApplication
ANDA 208269
Identifiers
- fda_app_no: ANDA208269
Properties
| Property | Value |
|---|---|
| applicant_name | ALVOGEN INC |
| application_type | ANDA |
| approval_date | 2021-03-01 |
Products (7)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HYDROCODONE BITARTRATE | HYDROCODONE BITARTRATE | 30MG | TABLET, EXTENDED RELEASE;ORAL |
| HYDROCODONE BITARTRATE | HYDROCODONE BITARTRATE | 120MG | TABLET, EXTENDED RELEASE;ORAL |
| HYDROCODONE BITARTRATE | HYDROCODONE BITARTRATE | 80MG | TABLET, EXTENDED RELEASE;ORAL |
| HYDROCODONE BITARTRATE | HYDROCODONE BITARTRATE | 60MG | TABLET, EXTENDED RELEASE;ORAL |
| HYDROCODONE BITARTRATE | HYDROCODONE BITARTRATE | 100MG | TABLET, EXTENDED RELEASE;ORAL |
| HYDROCODONE BITARTRATE | HYDROCODONE BITARTRATE | 40MG | TABLET, EXTENDED RELEASE;ORAL |
| HYDROCODONE BITARTRATE | HYDROCODONE BITARTRATE | 20MG | TABLET, EXTENDED RELEASE;ORAL |
7 products